Pfizer and BioNTech announced Tuesday that they’re beginning a clinical trial for an Omicron-specific Covid-19 vaccine. Moderna had previously revealed plans to develop its own vaccine that targets the variant, which is by far the dominant one in the United States right now.
How to think about boosters in light of this week's Pfizer and Moderna news
